159 related articles for article (PubMed ID: 12426945)
21. Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates.
Allen TM; Mumbengegwi DR; Charrois GJ
Clin Cancer Res; 2005 May; 11(9):3567-73. PubMed ID: 15867261
[TBL] [Abstract][Full Text] [Related]
22. Targeting of sterically stabilised pH-sensitive liposomes to human T-leukaemia cells.
Fonseca C; Moreira JN; Ciudad CJ; Pedroso de Lima MC; Simões S
Eur J Pharm Biopharm; 2005 Feb; 59(2):359-66. PubMed ID: 15661509
[TBL] [Abstract][Full Text] [Related]
23. Functional liposomal membranes for triggered release.
Koçer A
Methods Mol Biol; 2010; 605():243-55. PubMed ID: 20072885
[TBL] [Abstract][Full Text] [Related]
24. Intracellular regulation of macromolecules using pH-sensitive liposomes and nuclear localization signal: qualitative and quantitative evaluation of intracellular trafficking.
Tachibana R; Harashima H; Shono M; Azumano M; Niwa M; Futaki S; Kiwada H
Biochem Biophys Res Commun; 1998 Oct; 251(2):538-44. PubMed ID: 9792809
[TBL] [Abstract][Full Text] [Related]
25. Comparison of antisense oligonucleotide drug delivery systems.
Weyermann J; Lochmann D; Zimmer A
J Control Release; 2004 Dec; 100(3):411-23. PubMed ID: 15567506
[TBL] [Abstract][Full Text] [Related]
26. Oligonucleotide delivery to tumours using macromolecular carriers.
Dass CR
Biotechnol Appl Biochem; 2004 Oct; 40(Pt 2):113-22. PubMed ID: 15070400
[TBL] [Abstract][Full Text] [Related]
27. The use of pH-triggered leaky heterogeneities on rigid lipid bilayers to improve intracellular trafficking and therapeutic potential of targeted liposomal immunochemotherapy.
Karve S; Alaouie A; Zhou Y; Rotolo J; Sofou S
Biomaterials; 2009 Oct; 30(30):6055-64. PubMed ID: 19665223
[TBL] [Abstract][Full Text] [Related]
28. [Property of liposomal fusion induced by acid-sensitive polymer].
Wang RT; Chen T; Wang Z; Hui MQ; Fu JG
Yao Xue Xue Bao; 2008 Sep; 43(9):951-5. PubMed ID: 19048789
[TBL] [Abstract][Full Text] [Related]
29. Delivery of antiviral agents in liposomes.
Düzgüneş N; Simões S; Slepushkin V; Pretzer E; Flasher D; Salem II; Steffan G; Konopka K; Pedroso de Lima MC
Methods Enzymol; 2005; 391():351-73. PubMed ID: 15721391
[TBL] [Abstract][Full Text] [Related]
30. Serum-stable, long-circulating, pH-sensitive PEGylated liposomes.
Bertrand N; Simard P; Leroux JC
Methods Mol Biol; 2010; 605():545-58. PubMed ID: 20072905
[TBL] [Abstract][Full Text] [Related]
31. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
[TBL] [Abstract][Full Text] [Related]
32. Fluorometric immunoassay based on pH-sensitive dye-encapsulating liposomes and gramicidin channels.
Horie M; Yanagisawa H; Sugawara M
Anal Biochem; 2007 Oct; 369(2):192-201. PubMed ID: 17718997
[TBL] [Abstract][Full Text] [Related]
33. Heterogeneous domains and membrane permeability in phosphatidylcholine-phosphatidic acid rigid vesicles as a function of pH and lipid chain mismatch.
Karve S; Bajagur Kempegowda G; Sofou S
Langmuir; 2008 Jun; 24(11):5679-88. PubMed ID: 18471003
[TBL] [Abstract][Full Text] [Related]
34. Liposomal drug delivery systems--clinical applications.
Goyal P; Goyal K; Vijaya Kumar SG; Singh A; Katare OP; Mishra DN
Acta Pharm; 2005 Mar; 55(1):1-25. PubMed ID: 15907221
[TBL] [Abstract][Full Text] [Related]
35. [Acid-sensitive polymer liposomes prepared by poly(2-ethylacrylic acid) alkylamide derivatives].
Wang RT; Chen T; Wang Z; Lu TL; He YH
Yao Xue Xue Bao; 2007 Dec; 42(12):1303-8. PubMed ID: 18338645
[TBL] [Abstract][Full Text] [Related]
36. Long-circulating, pH-sensitive liposomes.
Momekova D; Rangelov S; Lambov N
Methods Mol Biol; 2010; 605():527-44. PubMed ID: 20072904
[TBL] [Abstract][Full Text] [Related]
37. Fusogenic liposome delivers encapsulated nanoparticles for cytosolic controlled gene release.
Kunisawa J; Masuda T; Katayama K; Yoshikawa T; Tsutsumi Y; Akashi M; Mayumi T; Nakagawa S
J Control Release; 2005 Jul; 105(3):344-53. PubMed ID: 15936842
[TBL] [Abstract][Full Text] [Related]
38. Targeted delivery of doxorubicin using stealth liposomes modified with transferrin.
Li X; Ding L; Xu Y; Wang Y; Ping Q
Int J Pharm; 2009 May; 373(1-2):116-23. PubMed ID: 19429296
[TBL] [Abstract][Full Text] [Related]
39. Trigger release liposome systems: local and remote controlled delivery?
Bibi S; Lattmann E; Mohammed AR; Perrie Y
J Microencapsul; 2012; 29(3):262-76. PubMed ID: 22208705
[TBL] [Abstract][Full Text] [Related]
40. Pharmaceutical approaches to colon targeted drug delivery systems.
Chourasia MK; Jain SK
J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
